title: Effects of various pretreatments on the hepatotoxicity of inhaled styrene in the B6C3F1 mouse.
abstract: 1. The roles of cytochrome P450 monooxygenases (P450) and glutathione (GSH) in styrene hepatotoxicity were investigated in mice by pretreating with either phenobarbital (PB; P450 inducer), SKF 525A (P450 inhibitor), N-acetylcysteine (NAC; GSH precursor), or saline (vehicle control) prior to a 6-h exposure to either 500 ppm styrene on air. 2. Styrene caused hepatocellular degeneration or necrosis in all groups; these changes were more extensive and severe in mice pretreated with PB. Styrene significantly increased relative liver weights and serum ALT and SDH levels only in mice pretreated with PB. NAC did not prevent GSH depletion or hepatotoxicity. 3. In the fat of SKF 525A-pretreated mice a slight but statistically significant increase in styrene levels was observed, suggesting that metabolism was decreased; the SO/styrene ratio in the fat of PB-pretreated mice showed a slight, but statistically significant, increase indicating a slight increase in styrene metabolism. Neither SKF 525A nor PB caused changes in microsomal enzyme activity in vitro. 4. These results suggest that styrene may be activated by a pathway not totally dependent upon P450 enzyme activity, or more likely that PB and SKF 525A are not specific for the P450 enzymes involved in activation and detoxification of styrene.
authors.affiliation: National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.
authors.forename: D L
authors.initials: DL
authors.lastname: Morgan
authors.forename: J F
authors.initials: JF
authors.lastname: Mahler
authors.forename: R E
authors.initials: RE
authors.lastname: Wilson
authors.forename: M P
authors.initials: MP
authors.lastname: Moorman
authors.forename: H C
authors.initials: HC
authors.lastname: Price
authors.forename: K R
authors.initials: KR
authors.lastname: Patrick
authors.forename: J H
authors.initials: JH
authors.lastname: Richards
authors.forename: R W
authors.initials: RW
authors.lastname: O'Connor
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism; D000280:Administration, Inhalation; D000818:Animals; D001835:Body Weight / Q000502:physiology; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000473:pathology*; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004790:Enzyme Induction / Q000187:drug effects; D004851:Epoxide Hydrolases / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008111:Liver Function Tests; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008862:Microsomes, Liver / Q000201:enzymology; D009929:Organ Size / Q000502:physiology; D013343:Styrenes / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity*
chemical_list: D065607:Cytochrome P-450 Enzyme Inhibitors; D013343:Styrenes; D003577:Cytochrome P-450 Enzyme System; D004851:Epoxide Hydrolases; D005978:Glutathione